Funding for this research was provided by:
The United Kingdom’s Department for International Development (DFID),
International Union Against Tuberculosis and Lung Disease
La Fondation Veuve Emile Metz-Tesch.
Received: 19 December 2016
Accepted: 8 March 2018
First Online: 16 May 2018
Ethics approval and consent to participate
: Permission to carry out the study was obtained from the Sudanese Ministry of Health and ethics approval was obtained from the Ethics Committee of the University of Medical Science and Technology, Khartoum, Sudan. This study fulfilled the exemption criteria set by the Ethics Review Board (ERB) of Médecins Sans Frontières (MSF), Geneva, Switzerland, for a-posteriori analyses of routinely collected data and thus did not require MSF ERB review. The study was also approved by the Ethics Advisory Group of the International Union Against Tuberculosis and Lung Disease, Paris, France (40/16). As this was a study using de-identified, routinely collected aggregated data, informed patient consent was not required.
: As this was a study using de-identified, routinely collected, aggregated data, informed patient consent was not required.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.